- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Gout
The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.
FDA Decisions to Watch in Rheumatology in Second Half of 2022
June 29, 2022
The approval and implementation of new drugs can vastly improve quality of life and reduce signs and symptoms of disease burden in patients with rheumatic and dermatologic diseases.
Rheumatology Network: Best of EULAR 2022
June 28, 2022
Take a few minutes to discover Rheumatology Network's most-viewed EULAR 2022 coverage.
Rheumatology Network's Top 5: June 25, 2022
June 25, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 25, 2022.
Plasma Levels of Glycoprotein Acetyls Linked to Incident Gout
June 22, 2022
Investigators identified novel biomarkers of incident gout and replicated novel metabolomic biomarkers of gout, including plasma levels of glycoprotein acetyls.
Gout Flares Predicted by Monosodium Urate Deposits, Subclinical Inflammation
June 14, 2022
Differences among baseline clinical and laboratory characteristics between cases and controls were observed in those with a presence of subcutaneous tophi and higher serum urate levels.
John K Botson, MD, RPh, CCD: Pegloticase Combination Therapy for Uncontrolled Gout
June 02, 2022
John K. Botson MD, RPh, CCD, discusses results from the MIRROR trial, which evaluated the efficacy and safety of pegloticase injection in combination with methotrexate in patients with uncontrolled gout.
Rheumatology Network's Top 5: May 14, 2022
May 14, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending May 14, 2022.
Healthy Lifestyle Modifications May Lower Risk of Genetically Induced Gout
May 11, 2022
While genetics are linked to gout diagnosis and lifestyle factors are related to risk, the association between healthy choices and risk mitigation remained unclear.
Gout Increases Risk of COVID-19-Related Death in Women
April 13, 2022
“Understanding the drivers of this increased risk in women with gout warrants further investigation in larger datasets," investigators stated.
Jeff Peterson, MD: FDA Announces Priority Review of Pegloticase Plus Methotrexate for Gout Treatment
April 05, 2022
Jeff Peterson, MD, explains the importance of the recent FDA announcement granting priority review of the Supplemental Biologics License Application for concomitant use of pegloticase injection (KRYSTEXXA) plus methotrexate for patients with uncontrolled gout.